Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR)

Clinical trial NCT07486024 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07486024
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

MDR-TB Tuberculosis Multi Drug Resistant Active Antibiotic Resistance Mycobacterium Tuberculosis

Start date: 2026-04-01
Primary completion: 2030-08-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.